Formulary Fuel Webinar Series

Pre-approval information

This is the first episode in the Formulary Fuel series. This 2-part episode is focused on pre-approval information exchange and how biopharma companies can leverage the FormularyDecisions platform to share this type of information with healthcare decision makers. Part 1 of this episode provides background information on pre-approval information exchange as well as commentary from healthcare decision maker. Part 2 describes how the FormularyDecisions platform can be used to share pre-approval information with healthcare decision makers in addition to details on how one biopharma company leveraged their subscription for a pre-approval product.

• Formulary Fuel Webinar Recording: PIE - Part 1
• Formulary Fuel Webinar Recording: PIE - Part 2

Biosimilars

This is the second episode in the Formulary Fuel series. This episode is focused on biosimilars and how biopharma companies can leverage the FormularyDecisions platform to share information with healthcare decision makers. This episode provides background on the biosimilars landscape, commentary from a healthcare decision maker, biosimilar comparative-effectiveness research from a subject matter expert with Biologics and Biosimilars Collective Intelligence Consortium (BBCIC), and describes how the FormularyDecisions platform and its award-winning Biosimilar Resource Hub can be used to share biosimilar information with healthcare decision makers.

• Formulary Fuel Webinar Recording: Biosimilars

Cell and gene therapy

This is the third episode in the Formulary Fuel series. This episode is focused on cell and gene therapies (CGTs) and how CGT biopharma companies can leverage FormularyDecisions to share information with healthcare decision makers. This episode provides (1.) background on the CGT landscape and challenges from subject matter expert Cori Gorman, PhD, MBA, Senior Director for Regulatory CMC at Cenorca|Pharmalex, (2.) commentary on CGT costs, types of evidence important for coverage decisions, and CGT reimbursement (current and future) from healthcare decision maker Diala Nicolas, PharmD, BCPS, Clinical Consultant Pharmacist Team Lead in Clinical Pharmacy Services at ForHealth Consulting at UMass Chan Medical School, and (3.) describes how the FormularyDecisions platform can be used to share pertinent and timely CGT information with healthcare decision makers.

• Formulary Fuel Webinar Recording: Cell and gene therapy

FormularyDecisions^® is owned and operated by Xcenda, LLC, which is a subsidiary of AmerisourceBergen. The contents of the webinars mentioned here are solely the opinions of the presenters and do not represent the opinions of Xcenda or AmerisourceBergen. Xcenda and AmerisourceBergen strongly encourage viewers to review all available information about the discussion topics and to rely on their own experience and expertise in making decisions related thereto. Viewers of the above webinars may not re-use material presented without the written consent of the relevant presenters and Xcenda.